Shanghai Henlius Biotech, Inc. (HENLIUS) has set 21 August 2026 as the date for its upcoming Board meeting. Directors will review and approve the consolidated interim results for the six months ended 30 June 2026 and consider declaring an interim dividend.
The meeting will also address other routine corporate matters. The current Board is chaired by non-executive director Wenjie Zhang and includes one executive director, six non-executive directors, and four independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments